Cargando…

Jab1 is a target of EGFR signaling in ERα-negative breast cancer

INTRODUCTION: c-Jun activation domain-binding protein-1 (Jab1) is a multifunctional signaling protein that previously has been shown to be a master regulator of a poor prognostic gene signature in invasive breast cancer and to mediate the action of S100A7. Since epidermal growth factor receptor (EGF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiaxu, Barnes, Rebecca O, West, Nathan R, Olson, Melanie, Chu, Jenny E, Watson, Peter H
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481501/ https://www.ncbi.nlm.nih.gov/pubmed/18534028 http://dx.doi.org/10.1186/bcr2105

Ejemplares similares

Jab
por: Boggon, Adam
Publicado: (2022)

The Impact of the No Jab No Play and No Jab No Pay Legislation in Australia: A Scoping Review
por: Burns, Sharyn, et al.
Publicado: (2023)

Free flu jabs for dentists jabs axed by NHS England
Publicado: (2022)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

Regulation of IMP3 by EGFR Signaling and Repression by ERβ: Implications for Triple Negative Breast Cancer
por: Samanta, Sanjoy, et al.
Publicado: (2012)

Free flu jab from dentists
por: Yeung, C. A.
Publicado: (2020)

India Unburdening the Pandemic: Jabs and Talks
por: Basu, Eilene, et al.
Publicado: (2023)

Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
por: Chen, Haoming, et al.
Publicado: (2021)

Native top-down proteomics reveals EGFR–ERα signaling crosstalk in breast cancer cells dissociates NUTF2 dimers to modulate ERα signaling and cell growth
por: Yates, John, et al.
Publicado: (2023)

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer
por: Wang, Li, et al.
Publicado: (2016)

Will vets be called upon to administer flu jabs?
Publicado: (2020)

The Effects of Biofeedback on Performance and Technique of the Boxing Jab
por: Chen, Mark A., et al.
Publicado: (2021)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
por: Reese, Jordan M, et al.
Publicado: (2014)

S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast
por: Emberley, Ethan D, et al.
Publicado: (2004)

YAP inhibits ERα and ER(+) breast cancer growth by disrupting a TEAD-ERα signaling axis
por: Li, Xu, et al.
Publicado: (2022)

Association of TRPS1 gene with different EMT markers in ERα-positive and ERα-negative breast cancer
por: Su, Peng, et al.
Publicado: (2014)

Flu jab shortage in Japan puts elderly at risk
por: McCurry, Justin
Publicado: (2004)

MERS vaccines advance, but will humans or camels get the jab?
por: Khamsi, Roxanne
Publicado: (2015)

Jab priority by race may have saved lives
por: Wilson, Clare
Publicado: (2021)

Third COVID-19 jab benefits people with MS
por: Lemprière, Sarah
Publicado: (2022)

Free flu jabs for dentists axed by NHS England
Publicado: (2022)

RANK-C Expression Sensitizes ER-Negative, EGFR-Positive Breast Cancer Cells to EGFR-Tyrosine Kinase Inhibitors (TKIs)
por: Sirinian, Chaido, et al.
Publicado: (2021)

Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
por: Li, Yuanyuan, et al.
Publicado: (2013)

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway
por: Zhu, Linlin, et al.
Publicado: (2018)

Porcine JAB1 significantly enhances apoptosis induced by staurosporine
por: Jiang, P, et al.
Publicado: (2013)

The hammer and the jab: Are COVID-19 lockdowns and vaccinations complements or substitutes?
por: Caulkins, J.P., et al.
Publicado: (2023)

α5‐nAChR contributes to epithelial‐mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer
por: Chen, Xiaowei, et al.
Publicado: (2020)

Huaier polysaccharide inhibits the stem-like characteristics of ERα-36(high) triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway
por: Hu, Baoquan, et al.
Publicado: (2019)

Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues
por: Poola, Indira, et al.
Publicado: (2007)

MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5
por: Wu, Balu, et al.
Publicado: (2019)

ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway
por: Li, Guangliang, et al.
Publicado: (2020)

NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway
por: Yu, SiZhe, et al.
Publicado: (2021)

Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
por: Hutchinson, Samantha A, et al.
Publicado: (2019)

Regulatory mechanisms and therapeutic potential of JAB1 in neurological development and disorders
por: Yang, Yu, et al.
Publicado: (2023)

Human estrogen receptor-α (ER-α) transactivation by selective estrogen receptor modulators (SERMs) on VIT regulatory region in ER-α-negative breast cancer cell line Evsa-T transiently transfected by ER-α
por: Nyamagana Butera, IP, et al.
Publicado: (2001)

Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells
por: Li, Yuanyuan, et al.
Publicado: (2010)

A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-α (ERα) Expression in ERα-Negative Breast Cancer Cells
por: Kala, Rishabh, et al.
Publicado: (2016)

Fulvestrant inhibits growth of triple negative breast cancer and synergizes with tamoxifen in ERα positive breast cancer by up-regulation of ERβ
por: Mishra, Ameet K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e0uepivssgt85jk6v0iab3sk39